Leadership
![Leadership Home](https://www.ultragenyx.com/wp-content/uploads/2023/01/leadership-home.png)
Our team of passionate biopharmaceutical leaders combines deep expertise in drug development and commercialization.
Meet our leadership teamPipeline
![Pipeline Card](https://www.ultragenyx.com/wp-content/uploads/2023/01/pipeline-two-card.png)
We have one of the largest and most diverse pipelines in rare disease.
Explore our pipelineLatest news
View more news >Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update
![Rare Perspective Home](https://www.ultragenyx.com/wp-content/uploads/2023/01/rare-persp-home.png)
Rare perspective
Insights and information on our approach to collaborating with rare disease communities, supporting our teammates at Ultragenyx, and developing new therapies for rare disease
Read our blog >